Yonhap Infomax NewsMar 19, 2025
Hanmi Pharmaceutical and Samsung Bioepis partner to launch Prolia biosimilar in South Korea, aiming to provide affordable osteoporosis treatment options through joint marketing efforts.
#YonhapInfomax #HanmiPharmaceutical #SamsungBioepis #ProliaBiosimilar #OsteoporosisTreatment #PharmaceuticalPartnership #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=54656
Hanmi Pharm and Samsung Bioepis Sign Agreement for Osteoporosis Drug Sales

Hanmi Pharmaceutical and Samsung Bioepis partner to launch Prolia biosimilar in South Korea, aiming to provide affordable osteoporosis treatment options through joint marketing efforts.

Yonhap Infomax